Multimodality Therapy for Carcinoma of the Bartholin Gland
Identifieur interne : 004B05 ( Istex/Curation ); précédent : 004B04; suivant : 004B06Multimodality Therapy for Carcinoma of the Bartholin Gland
Auteurs : L. Stewart Massad ; Koen De Geest [États-Unis]Source :
- Gynecologic Oncology [ 0090-8258 ] ; 1999.
Abstract
Objective. The aim of this study was to report the value of chemoradiation in the management of cancers of the Bartholin gland. Methods. Primary treatment consisting of 45–46 Gy teletherapy radiation to the vulva, pelvis, and groins in combination with 50 mg/m2 of cisplatin and 1000 mg/m2/day of 5-fluorouracil for 5 days during the first and fifth weeks of irradiation was delivered, followed by intersititial implant or excision. Results. Two patients were free of disease at 30 and 59 months following therapy. Both patients required myocutaneous flap closure, one after excision of tumor after radiation and one after radionecrosis at the implant site. Conclusions. Primary chemoradiation may allow continence-sparing therapy for women with primary carcinoma of the Bartholin gland.
Url:
DOI: 10.1006/gyno.1999.5542
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :004B05
Links to Exploration step
ISTEX:9F915A0EB76520C6EA4ECC55664E01E7E663410BCuration
No country items
L. Stewart Massad<affiliation><mods:affiliation>Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Cook County Hospital, Chicago, Illinois, 60612</mods:affiliation><wicri:noCountry code="subField">60612</wicri:noCountry></affiliation>Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Multimodality Therapy for Carcinoma of the Bartholin Gland</title><author><name sortKey="Massad, L Stewart" sort="Massad, L Stewart" uniqKey="Massad L" first="L. Stewart" last="Massad">L. Stewart Massad</name><affiliation><mods:affiliation>Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Cook County Hospital, Chicago, Illinois, 60612</mods:affiliation><wicri:noCountry code="subField">60612</wicri:noCountry></affiliation></author><author><name sortKey="De Geest, Koen" sort="De Geest, Koen" uniqKey="De Geest K" first="Koen" last="De Geest">Koen De Geest</name><affiliation wicri:level="2"><mods:affiliation>Section of Gynecologic Oncology, Department of Obstetrics & Gynecology, Rush–Presbyterian, St. Luke's Medical Center, Chicago, Illinois</mods:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Illinois</region></placeName><wicri:cityArea>Section of Gynecologic Oncology, Department of Obstetrics & Gynecology, Rush–Presbyterian, St. Luke's Medical Center, Chicago</wicri:cityArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:9F915A0EB76520C6EA4ECC55664E01E7E663410B</idno><date when="1999" year="1999">1999</date><idno type="doi">10.1006/gyno.1999.5542</idno><idno type="url">https://api.istex.fr/document/9F915A0EB76520C6EA4ECC55664E01E7E663410B/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">004B05</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">004B05</idno><idno type="wicri:Area/Istex/Curation">004B05</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Multimodality Therapy for Carcinoma of the Bartholin Gland</title><author><name sortKey="Massad, L Stewart" sort="Massad, L Stewart" uniqKey="Massad L" first="L. Stewart" last="Massad">L. Stewart Massad</name><affiliation><mods:affiliation>Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, Cook County Hospital, Chicago, Illinois, 60612</mods:affiliation><wicri:noCountry code="subField">60612</wicri:noCountry></affiliation></author><author><name sortKey="De Geest, Koen" sort="De Geest, Koen" uniqKey="De Geest K" first="Koen" last="De Geest">Koen De Geest</name><affiliation wicri:level="2"><mods:affiliation>Section of Gynecologic Oncology, Department of Obstetrics & Gynecology, Rush–Presbyterian, St. Luke's Medical Center, Chicago, Illinois</mods:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Illinois</region></placeName><wicri:cityArea>Section of Gynecologic Oncology, Department of Obstetrics & Gynecology, Rush–Presbyterian, St. Luke's Medical Center, Chicago</wicri:cityArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Gynecologic Oncology</title><title level="j" type="abbrev">YGYNO</title><idno type="ISSN">0090-8258</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1999">1999</date><biblScope unit="volume">75</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="305">305</biblScope><biblScope unit="page" to="307">307</biblScope></imprint><idno type="ISSN">0090-8258</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0090-8258</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Objective. The aim of this study was to report the value of chemoradiation in the management of cancers of the Bartholin gland. Methods. Primary treatment consisting of 45–46 Gy teletherapy radiation to the vulva, pelvis, and groins in combination with 50 mg/m2 of cisplatin and 1000 mg/m2/day of 5-fluorouracil for 5 days during the first and fifth weeks of irradiation was delivered, followed by intersititial implant or excision. Results. Two patients were free of disease at 30 and 59 months following therapy. Both patients required myocutaneous flap closure, one after excision of tumor after radiation and one after radionecrosis at the implant site. Conclusions. Primary chemoradiation may allow continence-sparing therapy for women with primary carcinoma of the Bartholin gland.</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004B05 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 004B05 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:9F915A0EB76520C6EA4ECC55664E01E7E663410B
|texte= Multimodality Therapy for Carcinoma of the Bartholin Gland
}}
| This area was generated with Dilib version V0.6.31. |  |